Skip to content

A clinical study for the improvement of facial skin status with collagen peptide oral solution

A clinical study for the improvement of facial skin status with collagen peptide oral solution

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069080
Enrollment
Unknown
Registered
2023-03-06
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin improvement

Interventions

Group A:Collagen Peptide A
Group B:Collagen Peptide B
Group C:Collagen Peptide C(Placebo)

Sponsors

Fu Xing Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Healthy women aged 35 to 45; BMI 18.5-27.9 kg/m2; (2) Wrinkle severity rating scale (WSRS) score = 2; (3) According to Fitzpatrick Pathak's skin solar reactivity, it was classified as ? - ?; (4) Sign the informed consent form voluntarily; (5) The facial skin is basically intact without ulceration and exudation; (6) No invasive treatment, laser photo cosmetology or similar treatment was used on the face 3 months before the intervention; (7) No systemic oral or intramuscular injection of glucocorticoids, collagen, hyaluronic acid and other beauty drugs and health products 3 months before the intervention; (8) There was no significant change in lifestyle, including diet and skin care during the intervention period as before; (9) During the intervention, do not use any cosmetics, drugs and health products that have an impact on the results; (10) The regularity of life can be maintained during the intervention.

Exclusion criteria

Exclusion criteria: (1) Pregnant, pregnant, lactating and menopausal women; (2) Acute anaphylaxis period or anaphylaxis to test and control substance; (3) Patients with skin diseases (such as eczema, acne, psoriasis, etc.) or obvious redness, swelling and tattoos near the test area; (4) He is receiving medication or physical therapy in recent 3 months; (5) Subjects with severe primary diseases such as severe cardiovascular, cerebrovascular, hepatorenal and hematopoietic systems, and psychiatric disorders; (6) Take contraceptives now or in the last three months; (7) Take antibiotics now or in the last three months; (8) Being involved in other clinical trials; (9) Irregular work and rest; (10) The researcher thinks it is not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Facial spots;facial wrinkle;Facial texture;Skin color and complexion homogeneity;Skin moisturizing;

Countries

China

Contacts

Public ContactWenhui Huang

Fu Xing Hospital Ethics Committee

huangwenhui1013@163.com13671328297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026